phase clinic pharmacokinet trial flavon acet acid flavon acet acid synthet benzopyron deriv unknown mechan action thirty-eight patient men women week week week dose flavon acet acid dose equal drug hour dose equal infus period hour treatment patient hydrat treatment alkal urin pH equal dose-limit toxic effect hypotens pharmacokinet studi linear behavior patient peak plasma level micrograms/ml mean termin half-lif hour immunolog monitor patient transient increas and/or cell patient patient increas increas cell object tumor respons trial recommend phase II dose schedul further studi drug mechan action immunolog properti 